Glaucoma Patients Show Elevated Neurofilament Protein
Researchers identified increased neurofilament light chain levels in the aqueous humor of patients with glaucoma.
Updated on Sept. 21, 2026 in Alzheimer’s
Live Poll
Does reading about new glaucoma biomarkers make you more likely to schedule a comprehensive eye exam?
A new study has found that patients with primary open-angle glaucoma possess elevated neurofilament light chain levels in their aqueous humor. Researchers utilized an ultra-sensitive single-molecule array technique to identify the protein concentrations.
Why it matters
The findings provide new evidence regarding protein expression differences in glaucoma patients. These results suggest a potential new avenue for biomarker research, though further validation is required.
The study analyzed 38 patients with primary open-angle glaucoma and 62 cataract controls using ultra-sensitive single-molecule arrays. While aqueous humor levels showed statistical significance, plasma levels did not.
The players
Nature
Nature is a long-standing international journal that publishes peer-reviewed research across a wide range of scientific and technical disciplines.
The details
Researchers investigated the expression of neurofilament light chain and glial fibrillary acidic protein to better understand their roles in glaucoma. While the neurofilament protein showed elevated levels, glial fibrillary acidic protein levels remained unchanged across both plasma and aqueous humor samples.
Timeline
The findings were published on September 21, 2026.
The Big Picture
This study advances the ongoing investigation into neurofilament light chain as a biomarker for neurodegenerative disease by specifically exploring its expression within the eye. The findings extend the current scope of biomarker research by applying established neuro-analytical techniques to ophthalmic conditions.
This research is currently in an experimental phase and does not change existing treatment routines or diagnostic procedures for glaucoma patients. It highlights the need for larger studies to determine if these protein levels will eventually serve as a future clinical diagnostic tool.
The takeaway
This study identifies a potential biological marker in the eye that warrants further investigation regarding its role in glaucoma. Readers should note that this is early-stage research and does not currently impact standard clinical care or disease management.
Further reading
Learn more about advancements in neuro-related diagnostics on our Alzheimer’s section page.
More information
Read the complete peer-reviewed research article for more information.
Source note: This article includes information reported by Nature.
Live Poll
Does reading about new glaucoma biomarkers make you more likely to schedule a comprehensive eye exam?
